Full Text
The Full Text of this article is available as a PDF (35.0 KB).
editorial . 2001 May;84(9):1143–1145. doi: 10.1054/bjoc.2000.1740
Meta-analysis of single agents in the chemotherapy of NSCLC: what do we want to know?
A Bahl
1, S Falk
1
A Bahl
1Bristol Haematology and Oncology Centre, Horfield Rd, Bristol BS2 8ED, UK
Find articles by A Bahl
S Falk
1Bristol Haematology and Oncology Centre, Horfield Rd, Bristol BS2 8ED, UK
Find articles by S Falk
1Bristol Haematology and Oncology Centre, Horfield Rd, Bristol BS2 8ED, UK
Copyright © 2001 Cancer Research Campaign
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
PMCID: PMC2363895 PMID: 11336462